- Home
- ACIW vs CNTA Comparison
ACIW vs CNTA Comparison
Compare ACIW & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIW | CNTA |
|---|---|---|
| Founded | 1975 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.7B |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACIW | CNTA |
|---|---|---|
| Price | $40.52 | $23.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $62.50 | $38.50 |
| AVG Volume (30 Days) | 764.7K | ★ 1.5M |
| Earning Date | 02-26-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.89 | N/A |
| EPS | ★ 2.47 | N/A |
| Revenue | ★ $1,731,220,000.00 | $15,000,000.00 |
| Revenue This Year | $11.52 | N/A |
| Revenue Next Year | $6.92 | N/A |
| P/E Ratio | $16.56 | ★ N/A |
| Revenue Growth | 7.01 | ★ 118.88 |
| 52 Week Low | $38.89 | $9.60 |
| 52 Week High | $58.14 | $30.58 |
Technical Indicators
Market Signals| Indicator | ACIW | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 33.11 | 43.28 |
| Support Level | $38.89 | $23.82 |
| Resistance Level | $44.51 | $26.51 |
| Average True Range (ATR) | 1.51 | 1.46 |
| MACD | -0.30 | 0.12 |
| Stochastic Oscillator | 25.43 | 39.96 |
Price Performance
Historical ComparisonAbout ACIW ACI Worldwide Inc.
ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.